Katherine A. Fitzgerald, PhD, Fiachra Humphries, PhD, and Liraz Galia, PhD, working with the British-based pharmaceutical company GlaxoSmithKline, have identified a novel molecule capable of stimulating the innate immune system against SARS-CoV-2 virus.